EUCTR2012-004994-16-DE进行中（未招募）不适用
Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetes
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 603
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Male or female, age = 18 years at the time of signing inform consent
- •- BMI =25 and =40 kg/m^2
- •- Subjects diagnosed with T2D treated with diet and exercise and/or who have been on a stable dose of metformin for at least 30 days prior to screening
- •- HbA1c 7.0-9.5% (53-80 mmol/mol) (both inclusive)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 482
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 121
排除标准
- •- Subjects on selected oral medication with a narrow therapeutic window, such as warfarin, digoxin, tricyclic antidepressants, lithium, aminophylline, theophylline and anticonvulsants
- •- History of chronic pancreatitis or idiopathic acute pancreatitis
- •- Chronic malabsorption, regardless of aetiology
- •- History of Crohn’s disease, ulcerative colitis, or other inflammatory bowel disease
- •- Treatment with glucose lowering agent(s) other than metformin as stated in the inclusion criteria in a period of 90 days before the screening visit
研究者
相似试验
进行中（未招募）
不适用
Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2MedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-004994-16-ESovo Nordisk A/S603
进行中（未招募）
不适用
Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2012-004994-16-BGovo Nordisk A/S603
进行中（未招募）
不适用
Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2EUCTR2012-004994-16-SEovo Nordisk A/S603
进行中（未招募）
不适用
Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-004994-16-DKovo Nordisk A/S603
进行中（未招募）
不适用
Multiple dose trial examining dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetesDiabetes Mellitus, Type 2MedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-004994-16-ITovo Nordisk A/S603